Published in Aliment Pharmacol Ther on May 15, 2003
First-line eradication of H pylori infection in Europe: a meta-analysis based on congress abstracts, 1997-2004. World J Gastroenterol (2006) 0.82
Influence of pretreatment with H2 receptor antagonists on the cure rates of Helicobacter pylori eradication. Med Sci Monit (2011) 0.80
Cancer prevention and control: alarming challenges in China. Natl Sci Rev (2015) 0.79
Efficacy of microencapsulated lactic acid bacteria in Helicobater pylori eradication therapy. J Res Med Sci (2015) 0.76
Influence of antisecretory drugs on Helicobacter pylori eradication rates. Gut (2004) 0.75
Comparison of levofloxacin versus clarithromycin efficacy in the eradication of Helicobacter pylori infection. Caspian J Intern Med (2016) 0.75
Pharmacological regimens for eradication of Helicobacter pylori: an overview of systematic reviews and network meta-analysis. BMC Gastroenterol (2016) 0.75
Effectiveness of Second through Sixth Line Salvage Helicobacter pylori Treatment: Bismuth Quadruple Therapy is Almost Always a Reasonable Choice. Can J Gastroenterol Hepatol (2016) 0.75
Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut (2005) 7.35
Relationship between Helicobacter pylori iceA, cagA, and vacA status and clinical outcome: studies in four different countries. J Clin Microbiol (1999) 4.13
PDGF stimulation of inositol phospholipid hydrolysis requires PLC-gamma 1 phosphorylation on tyrosine residues 783 and 1254. Cell (1991) 3.95
Allelic variation in the cagA gene of Helicobacter pylori obtained from Korea compared to the United States. Am J Gastroenterol (1996) 3.20
Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study. Gut (2005) 2.90
The validity of viral hepatitis and chronic liver disease diagnoses in Veterans Affairs administrative databases. Aliment Pharmacol Ther (2007) 2.59
Point mutations in the 23S rRNA gene of Helicobacter pylori associated with different levels of clarithromycin resistance. J Antimicrob Chemother (1997) 2.47
Relationship between the cagA 3' repeat region of Helicobacter pylori, gastric histology, and susceptibility to low pH. Gastroenterology (1999) 2.44
The association of body mass index with Barrett's oesophagus. Aliment Pharmacol Ther (2005) 2.40
Demonstration of unexpected antibiotic resistance of genotypically identical Helicobacter pylori isolates. Clin Infect Dis (1998) 2.38
The association between gastro-oesophageal reflux disease and asthma: a systematic review. Gut (2007) 2.10
Molecular epidemiology of Helicobacter pylori: separation of H. pylori from East Asian and non-Asian countries. Epidemiol Infect (2000) 1.97
Systematic review: the global incidence and prevalence of peptic ulcer disease. Aliment Pharmacol Ther (2009) 1.83
6,7-Bis(bromomethyl)-2,11,18,21,24-pentaoxatetracyclo. Acta Crystallogr C (2001) 1.79
IFNalpha/beta promotes cell survival by activating NF-kappa B. Proc Natl Acad Sci U S A (2000) 1.74
Analysis of metronidazole, clarithromycin and tetracycline resistance of Helicobacter pylori isolates from Korea. J Antimicrob Chemother (2001) 1.68
The epidemiology of pancreatic cancer in the United States: changes below the surface. Aliment Pharmacol Ther (2006) 1.65
Etiology of Crohn's disease: the role of Mycobacterium avium paratuberculosis. Trends Mol Med (2001) 1.65
Helicobacter pylori outer membrane proteins and gastroduodenal disease. Gut (2005) 1.62
Challenge model for Helicobacter pylori infection in human volunteers. Gut (2004) 1.57
Risk factors for the development of renal dysfunction in hospitalized patients with cirrhosis. Am J Gastroenterol (2001) 1.56
Sequential therapy using high-dose esomeprazole-amoxicillin followed by gatifloxacin for Helicobacter pylori infection. Aliment Pharmacol Ther (2006) 1.54
Radiologic features of vasculitis involving the gastrointestinal tract. Radiographics (2000) 1.54
Seroepidemiological study of Helicobacter pylori infection in asymptomatic people in South Korea. J Gastroenterol Hepatol (2001) 1.53
Interferon alpha /beta promotes cell survival by activating nuclear factor kappa B through phosphatidylinositol 3-kinase and Akt. J Biol Chem (2001) 1.53
Twice daily (mid-day and evening) quadruple therapy for H. pylori infection in the United States. Dig Liver Dis (2004) 1.51
Mammalian heterogeneous ribonucleoprotein A1 and its constituent domains. Nucleic acid interaction, structural stability and self-association. J Mol Biol (1993) 1.49
Paclitaxel, 5-fluorouracil, and cisplatin combination chemotherapy for the treatment of advanced gastric carcinoma. Cancer (1999) 1.48
The prevalence of oesophageal eosinophilia and eosinophilic oesophagitis: a prospective study in unselected patients presenting to endoscopy. Aliment Pharmacol Ther (2013) 1.45
Review article: current treatment options and management of functional dyspepsia. Aliment Pharmacol Ther (2012) 1.45
The effects of freezing and antibiotics on the viability of Acanthamoeba cysts. Arch Ophthalmol (1989) 1.42
Analysis of rdxA and involvement of additional genes encoding NAD(P)H flavin oxidoreductase (FrxA) and ferredoxin-like protein (FdxB) in metronidazole resistance of Helicobacter pylori. Antimicrob Agents Chemother (2000) 1.42
Myelosuppression monitoring after immunomodulator initiation in veterans with inflammatory bowel disease: a national practice audit. Aliment Pharmacol Ther (2012) 1.40
Isolation of Helicobacter pylori from sheep-implications for transmission to humans. Am J Gastroenterol (2001) 1.40
Meta-analysis: the efficacy of over-the-counter gastro-oesophageal reflux disease therapies. Aliment Pharmacol Ther (2007) 1.39
Amoxycillin tolerance in Helicobacter pylori. J Antimicrob Chemother (1999) 1.38
The role of hepatitis C in hepatocellular carcinoma: a case control study among Egyptian patients. J Clin Gastroenterol (2001) 1.32
Alternative medicine use in HIV-positive men and women: demographics, utilization patterns and health status. AIDS Care (2001) 1.30
Adherence of Helicobacter pylori to areas of incomplete intestinal metaplasia in the gastric mucosa. Gastroenterology (1996) 1.29
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer. Br J Cancer (2008) 1.29
Prevalence of Helicobacter pylori infection in Korean children: inverse relation to socioeconomic status despite a uniformly high prevalence in adults. Am J Epidemiol (1996) 1.25
New myeloablative conditioning regimen with fludarabine and busulfan for allogeneic stem cell transplantation: comparison with BuCy2. Bone Marrow Transplant (2007) 1.21
Microsatellite instability in gastric intestinal metaplasia in patients with and without gastric cancer. Am J Pathol (2000) 1.20
Isolation and characterization of tetracycline-resistant clinical isolates of Helicobacter pylori. Antimicrob Agents Chemother (2000) 1.19
Effect of endplate conditions and bone mineral density on the compressive strength of the graft-endplate interface in anterior cervical spine fusion. Spine (Phila Pa 1976) (2001) 1.18
Regional differences in metronidazole resistance and increasing clarithromycin resistance among Helicobacter pylori isolates from Japan. Antimicrob Agents Chemother (2000) 1.18
Induction of homologous immune response to Rickettsia tsutsugamushi Boryong with a partial 56-kilodalton recombinant antigen fused with the maltose-binding protein MBP-Bor56. Infect Immun (1997) 1.16
Sclerosis of hepatic cavernous hemangioma: CT findings and pathologic correlation. J Korean Med Sci (1995) 1.16
A comparative study on the short-term clinicopathologic outcomes of laparoscopic surgery versus conventional open surgery for transverse colon cancer. Surg Endosc (2009) 1.15
The impact of hepatitis C burden: an evidence-based approach. Aliment Pharmacol Ther (2014) 1.14
Protective role of interleukin-10 promoter gene polymorphism in the pathogenesis of invasive pulmonary aspergillosis after allogeneic stem cell transplantation. Bone Marrow Transplant (2005) 1.14
Rapid diagnosis of Acanthamoeba keratitis using calcofluor white. Arch Ophthalmol (1986) 1.13
Conservation of Helicobacter pylori genotypes in different ethnic groups in Houston, Texas. J Infect Dis (2000) 1.12
Lagtimes in diagnosis and treatment of colorectal cancer: determinants and association with cancer stage and survival. Aliment Pharmacol Ther (2008) 1.12
DNA sequence analysis of rdxA and frxA from 12 pairs of metronidazole-sensitive and -resistant clinical Helicobacter pylori isolates. Antimicrob Agents Chemother (2001) 1.11
Furazolidone combination therapies for Helicobacter pylori infection in the United States. Aliment Pharmacol Ther (2000) 1.09
Cyclooxygenase-2 selectivity of non-steroidal anti-inflammatory drugs and the risk of myocardial infarction and cerebrovascular accident. Aliment Pharmacol Ther (2007) 1.08
Atrophic gastritis in young children and adolescents. J Clin Pathol (2005) 1.07
Systematic review: the epidemiology of eosinophilic oesophagitis in adults. Aliment Pharmacol Ther (2010) 1.07
Influence of endoscopic biopsy forceps characteristics on tissue specimens: results of a prospective randomized study. Gastrointest Endosc (1999) 1.06
Irritable bowel syndrome and dyspepsia among women veterans: prevalence and association with psychological distress. Aliment Pharmacol Ther (2008) 1.06
Different interactions used by Cro repressor in specific and nonspecific DNA binding. J Biol Chem (1986) 1.05
Bacterial contamination of eyedrop dispensers. Am J Ophthalmol (1984) 1.05
Furazolidone- and nitrofurantoin-resistant Helicobacter pylori: prevalence and role of genes involved in metronidazole resistance. Antimicrob Agents Chemother (2001) 1.04
Wernicke's encephalopathy after allogeneic stem cell transplantation. Bone Marrow Transplant (2005) 1.03
Early events in proton pump inhibitor-associated exacerbation of corpus gastritis. Aliment Pharmacol Ther (2003) 1.03
Patients' intuitive judgments about surveillance endoscopy in Barrett's esophagus: a review and application to models of decision-making. Dis Esophagus (2013) 1.03
A multicenter, phase II trial of everolimus in locally advanced or metastatic thyroid cancer of all histologic subtypes. Ann Oncol (2013) 1.03
Xanthogranulomatous cholecystitis: radiologic findings with histologic correlation that focuses on intramural nodules. AJR Am J Roentgenol (1999) 1.02
Sleep duration and incidence of colorectal cancer in postmenopausal women. Br J Cancer (2013) 1.02
Fumigant toxicity of volatile natural products from Korean spices and medicinal plants towards the rice weevil, Sitophilus oryzae (L). Pest Manag Sci (2001) 1.02
Infection with Helicobacter pylori expressing the cagA gene is not associated with an increased risk of developing peptic ulcer diseases in Korean patients. Scand J Gastroenterol (1998) 1.00
Helicobacter pylori in sheep milk. Lancet (1999) 1.00
Liposarcoma arising in a giant lipomatous polyp of the esophagus. Korean J Intern Med (1989) 0.99
Clinical epidemiology and natural history of gastroesophageal reflux disease. Yale J Biol Med (2000) 0.99
Expression of myelin transcription factor I (MyTI), a "zinc-finger" DNA-binding protein, in developing oligodendrocytes. Glia (1995) 0.98
Surgical and pathological outcomes of laparoscopic surgery for transverse colon cancer. Int J Colorectal Dis (2008) 0.98
Characterization of UV-irradiated dense/porous collagen membranes: morphology, enzymatic degradation, and mechanical properties. Yonsei Med J (2001) 0.96
Eosinophilic foreign body granuloma after multiple self-administered bee stings. Br J Dermatol (1998) 0.96
Frameshift mutations in rdxA and metronidazole resistance in North American Helicobacter pylori isolates. J Antimicrob Chemother (2000) 0.96
Imaging of occupational lung disease. Radiographics (2001) 0.96
Papillomavirus found in anorectal squamous carcinoma, not in colon adenocarcinoma. Arch Surg (1992) 0.95
Marked differences in the frequency of microsatellite instability in gastric cancer from different countries. Am J Gastroenterol (1999) 0.95
Microsurgical reversal of tubal sterilization: a report on 1,118 cases. Fertil Steril (1997) 0.94
Frame-shift mutations in NAD(P)H flavin oxidoreductase encoding gene (frxA) from metronidazole resistant Helicobacter pylori ATCC43504 and its involvement in metronidazole resistance. FEMS Microbiol Lett (2000) 0.94
Trauma history and risk of the irritable bowel syndrome in women veterans. Aliment Pharmacol Ther (2010) 0.93
Altered expression of the fragile histidine triad gene in primary gastric adenocarcinomas. Biochem Biophys Res Commun (2001) 0.93
Experimental evaluation of chlorhexidine gluconate for ocular antisepsis. Antimicrob Agents Chemother (1984) 0.92
Effect of H. pylori infection and CagA status on leukocyte counts and liver function tests: extra-gastric manifestations of H. pylori infection. Helicobacter (1998) 0.92
The transcriptional regulator Yin Yang 1 activates the myelin PLP gene. J Neurochem (2001) 0.92
Views of hepatitis C virus patients delayed from treatment for psychiatric reasons. J Viral Hepat (2007) 0.92
H. pylori in the pathogenesis of duodenal ulcer: interaction between duodenal acid load, bile, and H. pylori. Am J Gastroenterol (2000) 0.92
Empirical therapy versus diagnostic tests in gastroesophageal reflux disease: a medical decision analysis. Dig Dis Sci (1998) 0.92
Alternative embryo transfer on day 3 or day 5 for reducing the risk of multiple gestations. J Assist Reprod Genet (2001) 0.91